Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

June 01, 2011; Volume 337,Issue 3

Highlighted Papers

  • You have access
    Novel Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitors
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 571;
  • You have access
    Cancer Prevention and Use of “Classical” Non-Steroidal Anti-Inflammatory Agents?
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 571;
  • You have access
    Rationale for Extended Duration of Long Acting β Agonists
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 571;
  • You have access
    Controlling Chronic Tacrolimus-Induced Hypertension through Inhibition of Protein Kinase C βII
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 571;

Behavioral Pharmacology

  • You have access
    Behavioral and Cellular Modulation of l-DOPA-Induced Dyskinesia by β-Adrenoceptor Blockade in the 6-Hydroxydopamine-Lesioned Rat
    David Lindenbach, Corinne Y. Ostock, Karen L. Eskow Jaunarajs, Kristin B. Dupre, Christopher J. Barnum, Nirmal Bhide and Christopher Bishop
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 755-765; DOI: https://doi.org/10.1124/jpet.111.179416
  • You have access
    Anticonflict and Reinforcing Effects of Triazolam + Pregnanolone Combinations in Rhesus Monkeys
    Bradford D. Fischer and James K. Rowlett
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 805-811; DOI: https://doi.org/10.1124/jpet.111.180422
  • You have access
    The Role of Central Gastrin-Releasing Peptide and Neuromedin B Receptors in the Modulation of Scratching Behavior in Rats
    Pin-Yen Su and Mei-Chuan Ko
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 822-829; DOI: https://doi.org/10.1124/jpet.111.178970

Cardiovascular

  • You have access
    Dose-Dependent Modulatory Effects of Insulin on Glucose-Induced Endothelial Senescence In Vitro and In Vivo: A Relationship between Telomeres and Nitric Oxide
    Hisako Matsui-Hirai, Toshio Hayashi, Seiji Yamamoto, Koichiro Ina, Morihiko Maeda, Hitoshi Kotani, Akihisa Iguchi, Louis J. Ignarro and Yuichi Hattori
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 591-599; DOI: https://doi.org/10.1124/jpet.110.177584
  • You have access
    Doxycycline Ameliorates the Susceptibility to Aortic Lesions in a Mouse Model for the Vascular Type of Ehlers-Danlos Syndrome
    Wilfried Briest, Timothy K. Cooper, Hyun-Jin Tae, Melissa Krawczyk, Nazli B. McDonnell and Mark I. Talan
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 621-627; DOI: https://doi.org/10.1124/jpet.110.177782
  • You have access
    Protein Kinase CβII-Mediated Phosphorylation of Endothelial Nitric Oxide Synthase Threonine 495 Mediates the Endothelial Dysfunction Induced by FK506 (Tacrolimus)
    Valorie L. Chiasson, Matthew A. Quinn, Kristina J. Young and Brett M. Mitchell
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 718-723; DOI: https://doi.org/10.1124/jpet.110.178095
  • You have access
    Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1a Receptor Full Agonist for the Treatment of Vasodilatory Hypotension
    Régent Laporte, Arash Kohan, Joshua Heitzmann, Halina Wiśniewska, Jeannine Toy, Erin La, Hiroe Tariga, Sudarkodi Alagarsamy, Brian Ly, John Dykert, Steve Qi, Kazimierz Wiśniewski, Robert Galyean, Glenn Croston, Claudio D. Schteingart and Pierre J.-M. Rivière
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 786-796; DOI: https://doi.org/10.1124/jpet.111.178848

Cellular and Molecular

  • You have access
    Age Dependency of Inhibition of α7 Nicotinic Receptors and Tonically Active N-Methyl-d-aspartate Receptors by Endogenously Produced Kynurenic Acid in the Brain
    Manickavasagom Alkondon, Edna F. R. Pereira, Howard M. Eisenberg, Yasushi Kajii, Robert Schwarcz and Edson X. Albuquerque
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 572-582; DOI: https://doi.org/10.1124/jpet.110.177386
  • You have access
    Functional and Biochemical Rationales for the 24-Hour-Long Duration of Action of Olodaterol
    Paola Casarosa, Ines Kollak, Tobias Kiechle, Angela Ostermann, Andreas Schnapp, Ralf Kiesling, Michael Pieper, Peter Sieger and Florian Gantner
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 600-609; DOI: https://doi.org/10.1124/jpet.111.179259
  • You have access
    Efficacy of Ganitumab (AMG 479), Alone and in Combination with Rapamycin, in Ewing's and Osteogenic Sarcoma Models
    Pedro J. Beltran, Young-Ah Chung, Gordon Moody, Petia Mitchell, Elaina Cajulis, Steven Vonderfecht, Richard Kendall, Robert Radinsky and Frank J. Calzone
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 644-654; DOI: https://doi.org/10.1124/jpet.110.178400
  • You have access
    Characterization of Vabicaserin (SCA-136), a Selective 5-Hydroxytryptamine 2C Receptor Agonist
    John Dunlop, Stephanie W. Watts, James E. Barrett, Joseph Coupet, Boyd Harrison, Hossein Mazandarani, Stanley Nawoschik, Menelas N. Pangalos, Siva Ramamoorthy, Lee Schechter, Deborah Smith, Gary Stack, Jean Zhang, Guoming Zhang and Sharon Rosenzweig-Lipson
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 673-680; DOI: https://doi.org/10.1124/jpet.111.179572
  • You have access
    Nitrite-Mediated Modulation of HL-60 Cell Cycle and Proliferation: Involvement of Cyclin-Dependent Kinase 2 Activation
    Sachin Kumar, Manoj Kumar Barthwal and Madhu Dikshit
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 812-821; DOI: https://doi.org/10.1124/jpet.110.177444
  • You have access
    Heteromerization of the μ- and δ-Opioid Receptors Produces Ligand-Biased Antagonism and Alters μ-Receptor Trafficking
    Laura Milan-Lobo and Jennifer L. Whistler
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 868-875; DOI: https://doi.org/10.1124/jpet.111.179093

Chemotherapy, Antibiotics, and Gene Therapy

  • You have access
    Tipifarnib-Induced Apoptosis in Acute Myeloid Leukemia and Multiple Myeloma Cells Depends on Ca2+ Influx through Plasma Membrane Ca2+ Channels
    Niranjan Yanamandra, Robert W. Buzzeo, Mark Gabriel, Lori A. Hazlehurst, Yelenis Mari, Darrin M. Beaupre and Javier Cuevas
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 636-643; DOI: https://doi.org/10.1124/jpet.110.172809
  • You have access
    Mitochondria Determine the Efficacy of Anticancer Agents that Interact with DNA but Not the Cytoskeleton
    Kenjirou Hara, Emiko Kasahara, Nozomi Takahashi, Masami Konishi, June Inoue, Mika Jikumaru, Shuji Kubo, Haruki Okamura, Eisuke Sato and Masayasu Inoue
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 838-845; DOI: https://doi.org/10.1124/jpet.111.179473

Drug Discovery and Translational Medicine

  • You have access
    Agonist-Induced Internalization of CC Chemokine Receptor 5 as a Mechanism to Inhibit HIV Replication
    Thierry Ferain, Hamid Hoveyda, Frédéric Ooms, Dominique Schols, Jérôme Bernard and Graeme Fraser
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 655-662; DOI: https://doi.org/10.1124/jpet.111.179622
  • You have access
    Discovery of a Calcimimetic with Differential Effects on Parathyroid Hormone and Calcitonin Secretion
    Charles Henley, Yuhua Yang, James Davis, Jenny Ying Lin Lu, Sean Morony, Wei Fan, Monica Florio, Banghua Sun, Edward Shatzen, James K. Pretorius, William G. Richards, David J. St. Jean, Christopher Fotsch and Jeff D. Reagan
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 681-691; DOI: https://doi.org/10.1124/jpet.110.178681

Endocrine and Diabetes

  • You have access
    Mechanistic Modeling of the Effects of Glucocorticoids and Circadian Rhythms on Adipokine Expression
    Siddharth Sukumaran, William J. Jusko, Debra C. DuBois and Richard R. Almon
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 734-746; DOI: https://doi.org/10.1124/jpet.111.179960
  • You have access
    Inhibitory Effects of Antivascular Endothelial Growth Factor Strategies in Experimental Dopamine-Resistant Prolactinomas
    Guillermina María Luque, Maria Ines Perez-Millán, Ana Maria Ornstein, Carolina Cristina and Damasia Becu-Villalobos
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 766-774; DOI: https://doi.org/10.1124/jpet.110.177790

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • You have access
    Role of Intrarenal Angiotensin System Activation, Oxidative Stress, Inflammation, and Impaired Nuclear Factor-Erythroid-2-Related Factor 2 Activity in the Progression of Focal Glomerulosclerosis
    Hyun Ju Kim, Tadashi Sato, Bernardo Rodríguez-Iturbe and Nosratola D. Vaziri
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 583-590; DOI: https://doi.org/10.1124/jpet.110.175828
  • You have access
    Impact of a Glycogen Phosphorylase Inhibitor and Metformin on Basal and Glucagon-Stimulated Hepatic Glucose Flux in Conscious Dogs
    Tracy P. Torres, Noriyasu Sasaki, E. Patrick Donahue, Brooks Lacy, Richard L. Printz, Alan D. Cherrington, Judith L. Treadway and Masakazu Shiota
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 610-620; DOI: https://doi.org/10.1124/jpet.110.177899
  • You have access
    Reduction of Fibrogenesis by Selective Delivery of a Rho Kinase Inhibitor to Hepatic Stellate Cells in Mice
    M. M. van Beuge, J. Prakash, M. Lacombe, R. Gosens, E. Post, C. Reker-Smit, L. Beljaars and K. Poelstra
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 628-635; DOI: https://doi.org/10.1124/jpet.111.179143
  • You have access
    A Small-Molecule Inhibitor of Enterocytic Microsomal Triglyceride Transfer Protein, SLx-4090: Biochemical, Pharmacodynamic, Pharmacokinetic, and Safety Profile
    Enoch Kim, Stewart Campbell, Olivier Schueller, Eric Wong, Bridget Cole, Jay Kuo, James Ellis, John Ferkany and Paul Sweetnam
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 775-785; DOI: https://doi.org/10.1124/jpet.110.177527
  • You have access
    A Study Comparing the Antisecretory Effect of TAK-438, a Novel Potassium-Competitive Acid Blocker, with Lansoprazole in Animals
    Yasunobu Hori, Jun Matsukawa, Toshiyuki Takeuchi, Haruyuki Nishida, Masahiro Kajino and Nobuhiro Inatomi
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 797-804; DOI: https://doi.org/10.1124/jpet.111.179556

Inflammation, Immunopharmacology, and Asthma

  • You have access
    Sphingosine-1-Phosphate Modulates Vascular Permeability and Cell Recruitment in Acute Inflammation In Vivo
    Fiorentina Roviezzo, Vincenzo Brancaleone, Luana De Gruttola, Valentina Vellecco, Mariarosaria Bucci, Bruno D'Agostino, Dianne Cooper, Raffaella Sorrentino, Mauro Perretti and Giuseppe Cirino
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 830-837; DOI: https://doi.org/10.1124/jpet.111.179168

Metabolism, Transport, and Pharmacogenomics

  • You have access
    Glucuronidation of Anticancer Prodrug PR-104A: Species Differences, Identification of Human UDP-Glucuronosyltransferases, and Implications for Therapy
    Yongchuan Gu, Malcolm D. Tingle and William R. Wilson
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 692-702; DOI: https://doi.org/10.1124/jpet.111.180703
  • You have access
    P-Glycoprotein (ABCB1) Transports the Primary Active Tamoxifen Metabolites Endoxifen and 4-Hydroxytamoxifen and Restricts Their Brain Penetration
    Dilek Iusuf, Sebastiaan F. Teunissen, Els Wagenaar, Hilde Rosing, Jos H. Beijnen and Alfred H. Schinkel
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 710-717; DOI: https://doi.org/10.1124/jpet.110.178301
  • You have access
    1α,25-Dihydroxyvitamin D3 Up-Regulates P-Glycoprotein via the Vitamin D Receptor and Not Farnesoid X Receptor in Both fxr(−/−) and fxr(+/+) Mice and Increased Renal and Brain Efflux of Digoxin in Mice In Vivo
    Edwin C. Y. Chow, Matthew R. Durk, Carolyn L. Cummins and K. Sandy Pang
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 846-859; DOI: https://doi.org/10.1124/jpet.111.179101
  • You have access
    Phospho-Ibuprofen (MDC-917) Is a Novel Agent against Colon Cancer: Efficacy, Metabolism, and Pharmacokinetics in Mouse Models
    Gang Xie, Yu Sun, Ting Nie, Gerardo G. Mackenzie, Liqun Huang, Levy Kopelovich, Despina Komninou and Basil Rigas
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 876-886; DOI: https://doi.org/10.1124/jpet.111.180224

Neuropharmacology

  • You have access
    Treatment with Z-Ligustilide, a Component of Angelica sinensis, Reduces Brain Injury after a Subarachnoid Hemorrhage in Rats
    Di Chen, Jiping Tang, Nikan H. Khatibi, Mei Zhu, Yingbo Li, Chengyuan Wang, Rong Jiang, Liu Tu and Shali Wang
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 663-672; DOI: https://doi.org/10.1124/jpet.110.177055
  • You have access
    Design of Novel Melatonin Analogs for the Reduction of Intraocular Pressure in Normotensive Rabbits
    Pilar Alarma-Estrany, Ana Guzman-Aranguez, Fernando Huete, Assumpta Peral, Robert Plourde, Teresa Pelaez, Benjamin Yerxa and Jesús Pintor
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 703-709; DOI: https://doi.org/10.1124/jpet.110.178319
  • You have access
    Previous Exposure to Δ9-Tetrahydrocannibinol Enhances Locomotor Responding to but Not Self-Administration of Amphetamine
    James J. Cortright, Daniel S. Lorrain, Jeff A. Beeler, Wei-Jen Tang and Paul Vezina
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 724-733; DOI: https://doi.org/10.1124/jpet.111.180208
  • You have access
    Kaempferol Attenuates 4-Hydroxynonenal-Induced Apoptosis in PC12 Cells by Directly Inhibiting NADPH Oxidase
    Young Jin Jang, Jiyoung Kim, Jaesung Shim, Jaekyoon Kim, Sanguine Byun, Min-Ho Oak, Ki Won Lee and Hyong Joo Lee
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 747-754; DOI: https://doi.org/10.1124/jpet.110.176925
  • You have access
    Toward Selective Drug Development for the Human 5-Hydroxytryptamine 1E Receptor: A Comparison of 5-Hydroxytryptamine 1E and 1F Receptor Structure-Affinity Relationships
    Michael T. Klein, Małgorzata Dukat, Richard A. Glennon and Milt Teitler
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 860-867; DOI: https://doi.org/10.1124/jpet.111.179606

Erratum

  • You have access
    Correction to “Inhibition of Anandamide Hydrolysis by Cyclohexyl Carbamic Acid 3′-Carbamoyl-3-yl Ester (URB597) Reverses Abuse-Related Behavioral and Neurochemical Effects of Nicotine in Rats”
    Journal of Pharmacology and Experimental Therapeutics June 2011, 337 (3) 887;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 337 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 337, Issue 3
1 Jun 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Highlighted Papers
  • Behavioral Pharmacology
  • Cardiovascular
  • Cellular and Molecular
  • Chemotherapy, Antibiotics, and Gene Therapy
  • Drug Discovery and Translational Medicine
  • Endocrine and Diabetes
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Inflammation, Immunopharmacology, and Asthma
  • Metabolism, Transport, and Pharmacogenomics
  • Neuropharmacology
  • Erratum
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics